Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Sympathetic Signaling01:31

Sympathetic Signaling

Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Friendships and Close Friendships01:20

Friendships and Close Friendships

Friendship formation is a dynamic process shaped by psychological, cultural, and social factors. Friendships play a crucial role in emotional well-being, social development, and personal identity from childhood to adulthood.Childhood and Early FriendshipsFriendships in childhood often arise due to shared environments, such as school or neighborhood interactions. At this stage, proximity and common interests serve as the primary basis for connection. As children grow, their friendships evolve...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Richard Gatti: From concert pianist to bone marrow transplants and the DNA damage response syndrome, ataxia-telangiectasia.

DNA repair·2026
Same author

ZC3H4 safeguards genome integrity by preventing transcription-replication conflicts at noncoding RNA loci.

Science advances·2025
Same author

Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse.

Science signaling·2025
Same author

Visualizing the DNA Damage Response in Purkinje Cells Using Cerebellar Organotypic Cultures.

Journal of visualized experiments : JoVE·2025
Same author

The cGAS-STING, p38 MAPK, and p53 pathways link genome instability to accelerated cellular senescence in ATM-deficient murine lung fibroblasts.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Broad repression of DNA repair genes in senescent cells identified by integration of transcriptomic data.

Nucleic acids research·2024

Related Experiment Video

Updated: May 7, 2026

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
14:47

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry

Published on: May 17, 2016

USP10: friend and foe.

Aart G Jochemsen1, Yosef Shiloh

  • 1Department of Molecular Cell Biology, Leiden University Medical Center, 2300RC Leiden, The Netherlands. a.g.jochemsen@lumc.nl

Cell
|February 11, 2010
PubMed
Summary

Researchers discovered USP10, a deubiquitinating protease, regulates the tumor suppressor protein p53. This finding is crucial for understanding DNA damage response and tumor development.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • The tumor suppressor protein p53 is vital for the DNA damage response.
  • p53 activity is primarily regulated through ubiquitination.
  • Understanding p53 regulation is key to cancer development research.

Purpose of the Study:

  • To identify novel regulators of p53 in the DNA damage response.
  • To investigate the role of deubiquitinating proteases in p53 regulation.
  • To explore the implications of p53 regulation in tumor development.

Main Methods:

  • Investigated the interaction between USP10 and p53.
  • Assessed the impact of USP10 on p53 ubiquitination levels.
  • Examined the functional consequences of USP10-mediated p53 regulation in cellular models.

More Related Videos

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
10:10

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on: March 31, 2019

Related Experiment Videos

Last Updated: May 7, 2026

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
14:47

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry

Published on: May 17, 2016

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
10:10

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on: March 31, 2019

Main Results:

  • Identified USP10 as a deubiquitinating protease that directly interacts with p53.
  • Demonstrated that USP10 deubiquitinates p53, affecting its stability and activity.
  • Showcased USP10's role in modulating the DNA damage response pathway through p53 regulation.

Conclusions:

  • USP10 is a newly identified regulator of the tumor suppressor protein p53.
  • USP10 influences the DNA damage response and has implications for tumor development.
  • Targeting USP10 may offer new therapeutic strategies for cancer treatment.